Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
MasterCraft Boat Holdings
MCFT
$600M
| $9.9M | 0.01% |
393,045
+256,038
| +187% | +$6.18M |
|
1327
Corcept Therapeutics
CORT
$13.3B
| $9.89M | 0.01% |
601,408
-576,810
| -49% | -$10.7M |
|
|
CNCE
1328
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $9.89M | 0.01% |
431,883
-294,002
| -41% | -$6.54M |
|
1329
PUT
iShares US Home Construction ETF
ITB
$2.27B
| $9.87M | 0.01% |
+250,000
| New | +$10.4M |
|
|
KRA
1330
DELISTED
Kraton Corporation
KRA
| $9.87M | 0.01% |
206,907
+148,617
| +255% | +$7.19M |
|
1331
Peapack-Gladstone Financial
PGC
$802M
| $9.87M | 0.01% |
295,621
+58,513
| +25% | +$2.04M |
|
1332
Unifirst Corp
UNF
$5.29B
| $9.87M | 0.01% |
61,033
+22,373
| +58% | +$3.59M |
|
1333
SolarEdge
SEDG
$1.88B
| $9.84M | 0.01% |
187,053
-155,826
| -45% | -$6.83M |
|
1334
CNO Financial Group
CNO
$4.98B
| $9.82M | 0.01% |
453,264
+52,740
| +13% | +$1.24M |
|
|
ESL
1335
DELISTED
Esterline Technologies
ESL
| $9.82M | 0.01% |
134,255
-71,754
| -35% | -$5.34M |
|
1336
Vishay Precision Group
VPG
$885M
| $9.82M | 0.01% |
315,212
-7,730
| -2% | -$220K |
|
1337
Phibro Animal Health
PAHC
$1.44B
| $9.81M | 0.01% |
247,198
-172,800
| -41% | -$6.4M |
|
1338
Kura Oncology
KURA
$1.2B
| $9.79M | 0.01% |
522,211
+218,306
| +72% | +$4.25M |
|
|
AEL
1339
DELISTED
American Equity Investment Life Holding Company
AEL
| $9.79M | 0.01% |
333,400
-271,885
| -45% | -$8.7M |
|
|
STEL
1340
DELISTED
Stellar Bancorp
STEL
| $9.78M | 0.01% |
332,290
+181,302
| +120% | +$5.22M |
|
1341
BancFirst
BANF
$3.76B
| $9.75M | 0.01% |
+183,644
| New | +$10M |
|
1342
Chesapeake Utilities
CPK
$3.28B
| $9.74M | 0.01% |
138,449
+78,623
| +131% | +$5.6M |
|
|
ESPR
1343
DELISTED
Esperion Therapeutics
ESPR
| $9.73M | 0.01% |
134,503
-253,444
| -65% | -$18.6M |
|
1344
Enpro
NPO
$6.45B
| $9.69M | 0.01% |
125,245
-240,504
| -66% | -$19.8M |
|
|
ADVM
1345
DELISTED
Adverum Biotechnologies
ADVM
| $9.68M | 0.01% |
166,830
+142,688
| +591% | +$8.88M |
|
1346
Zumiez
ZUMZ
$309M
| $9.67M | 0.01% |
404,602
+352,562
| +677% | +$7.53M |
|
1347
Cemex
CX
$15.8B
| $9.67M | 0.01% |
1,460,539
-2,949,091
| -67% | -$22.1M |
|
1348
Group 1 Automotive
GPI
$3.09B
| $9.62M | 0.01% |
147,226
-165,473
| -53% | -$12.2M |
|
1349
State Street Health Care Select Sector SPDR ETF
XLV
$45.4B
| $9.62M | 0.01% |
118,131
-173,477
| -59% | -$14.8M |
|
1350
Gibraltar Industries
ROCK
$1.38B
| $9.61M | 0.01% |
283,956
-184,908
| -39% | -$6.42M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.